The Scientific American reports on a new analysis of antidepressant trials revealing that the vast majority of meta-analyses have industry links and suppress negative results. The results show that meta-analyses with industry support were much more favorable to the drugs than independent studies. For example, “meta-analyses by industry employees were 22 times less likely to have negative statements about a drug than those run by unaffiliated researchers.”
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.